TGF-β can also be produced by KCs or even hepatocytes themselves, contributing to the complex interaction in the progression of MASLD, making it a signalling target for managing liver fibrosis [113]. The gene discussed is TBCE; the disease is metabolic dysfunction-associated steatotic liver disease.